Aimei Health Technology Co., Ltd (NASDAQ:AFJK - Get Free Report) was the recipient of a large decline in short interest in August. As of August 31st, there was short interest totalling 1,000 shares, a decline of 9.1% from the August 15th total of 1,100 shares. Currently, 0.0% of the company's stock are sold short. Based on an average daily volume of 16,700 shares, the days-to-cover ratio is currently 0.1 days.
Institutional Trading of Aimei Health Technology
A number of institutional investors have recently bought and sold shares of AFJK. Karpus Management Inc. purchased a new stake in Aimei Health Technology during the 1st quarter worth about $11,249,000. Wealthspring Capital LLC purchased a new stake in Aimei Health Technology during the 1st quarter worth about $5,483,000. Shaolin Capital Management LLC purchased a new stake in Aimei Health Technology during the 1st quarter worth about $3,078,000. Mizuho Securities USA LLC purchased a new stake in Aimei Health Technology during the 1st quarter worth about $2,724,000. Finally, Periscope Capital Inc. purchased a new stake in Aimei Health Technology during the 1st quarter worth about $1,536,000. 45.58% of the stock is owned by hedge funds and other institutional investors.
Aimei Health Technology Price Performance
NASDAQ AFJK remained flat at $10.48 during trading on Tuesday. The company's stock had a trading volume of 6,798 shares, compared to its average volume of 56,483. The stock has a 50-day simple moving average of $10.41 and a 200 day simple moving average of $10.33. Aimei Health Technology has a 12 month low of $10.15 and a 12 month high of $10.51.
About Aimei Health Technology
(
Get Free Report)
Aimei Health Technology Co, Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. The company was incorporated in 2023 and is based in New York, New York.
See Also
Before you consider Aimei Health Technology, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aimei Health Technology wasn't on the list.
While Aimei Health Technology currently has a "hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
